FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.10  |  FHIR Version n/a  User: [n/a]

27992811000001102: Reltebon 15mg modified-release tablets (Actavis UK Ltd) (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 10-Dec 2014. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
88038701000001110 Reltebon 15mg modified-release tablets (Actavis UK Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
112980901000001117 Reltebon 15mg modified-release tablets (Accord Healthcare Ltd) en Synonym Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Reltebon 15mg modified-release tablets (Actavis UK Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Reltebon 15mg modified-release tablets (Actavis UK Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category Schedule 2 (CD) true Inferred relationship Existential restriction modifier
Reltebon 15mg modified-release tablets (Actavis UK Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Reltebon 15mg modified-release tablets (Actavis UK Ltd) Is a Oxycodone hydrochloride 15mg m/r tablet false Inferred relationship Existential restriction modifier
Reltebon 15mg modified-release tablets (Actavis UK Ltd) Has active ingredient Oxycodone hydrochloride true Inferred relationship Existential restriction modifier
Reltebon 15mg modified-release tablets (Actavis UK Ltd) Has manufactured dose form Modified-release oral tablet true Inferred relationship Existential restriction modifier
Reltebon 15mg modified-release tablets (Actavis UK Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Reltebon 15mg modified-release tablets (Actavis UK Ltd) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Reltebon 15mg modified-release tablets (Actavis UK Ltd) Has specific active ingredient Oxycodone hydrochloride true Inferred relationship Existential restriction modifier
Reltebon 15mg modified-release tablets (Actavis UK Ltd) Has dispensed dose form Modified-release oral tablet true Inferred relationship Existential restriction modifier
Reltebon 15mg modified-release tablets (Actavis UK Ltd) Has excipient Lactose false Inferred relationship Existential restriction modifier
Reltebon 15mg modified-release tablets (Actavis UK Ltd) Is a Reltebon true Inferred relationship Existential restriction modifier
Reltebon 15mg modified-release tablets (Actavis UK Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Reltebon 15mg modified-release tablets (Actavis UK Ltd) Is a Oxycodone 15mg modified-release tablets false Inferred relationship Existential restriction modifier
Reltebon 15mg modified-release tablets (Actavis UK Ltd) Is a Oxycodone 15mg modified-release tablets true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Reltebon 15mg modified-release tablets (Actavis UK Ltd) 56 tablet 4 x 14 tablets Has AMP True Reltebon 15mg modified-release tablets (Actavis UK Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start